Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Postirradiation squamous cell carcinoma in situ of the vagina: treatment by topical 20 percent 5-fluorouracil cream

Journal Article · · Am. J. Obstet. Gynecol.; (United States)
OSTI ID:5824695

Eight patients with squamous cell carcinoma in situ of the vagina were treated with monthly 5 day courses of 20% 5-fluorouracil cream applied to the vagina. Seven (87.5%) of the women had an initial complete response; however, three subsequently developed recurrence after the treatment was stopped. They were retreated, and two of these three patients achieved a subsequent complete response. The overall response to therapy was 75% (6/8) with the six women off therapy from 1.1 to 6.9 years. Total follow-up of all patients was 3.1 to 6.9 years with no patients having developed invasive carcinoma. Because of the high success rate with no associated serious sequelae, this is believed to be a satisfactory method of therapy for women with squamous cell carcinoma in situ of the vagina occurring after pelvic irradiation.

Research Organization:
Roswell Park Memorial Inst., Buffalo, NY
OSTI ID:
5824695
Journal Information:
Am. J. Obstet. Gynecol.; (United States), Journal Name: Am. J. Obstet. Gynecol.; (United States) Vol. 135:3; ISSN AJOGA
Country of Publication:
United States
Language:
English

Similar Records

Carcinoma of vagina 10 or more years following pelvic irradiation therapy
Journal Article · Mon Feb 28 23:00:00 EST 1977 · Am. J. Obstet. Gynecol.; (United States) · OSTI ID:7120492

Definitive radiation therapy for squamous cell carcinoma of the vagina
Journal Article · Sun May 01 00:00:00 EDT 2005 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:20698420

Treatment of 29 patients with bulky squamous cell carcinoma of the cervix with simultaneous cisplatin, 5-fluorouracil, and split-course hyperfractionated radiation therapy
Journal Article · Sat Sep 01 00:00:00 EDT 1990 · Gynecologic Oncology; (USA) · OSTI ID:6069463